Results 101 to 110 of about 3,879,257 (291)

Lifestyle modification and hypertension prevention [PDF]

BACKGROUND: Hypertension, a clear risk factor for cardiovascular diseases, affects nearly one billion people worldwide. Recent statistics have reported increasing mortality due to hypertension which reveals the importance of prophylactic strategies in ...
قربانی, اعظم, قزلباش, سيما   +1 more
core  

Screening and management of hypertensive patients with chronic kidney disease referred to Hypertension Excellence Centres among 27 countries. A pilot survey based on questionnaire.

Real-life management of hypertensive patients with chronic kidney disease (CKD) is unclear. A survey was conducted in 2023 by the European Society of Hypertension (ESH) to assess management of CKD patients referred to ESH-Hypertension Excellence Centres (
Mayer, G., Dusing, R., Limbourg, F.P., Saeed, S., Rump, L.C., Kreutz, R., Ruilope, L.M., Águila, F.J., Triantafyllidi, H., Robles, N.R., Tabbalat, R., Polónia, J., Solbu, M., Venzin, R.M., Wuerzner, G., Paixão-Dias, V., Bilo, G., van der Giet, M., Van der Niepen, P., Izzo, R., Zelveian, P., Viigimaa, M., Nasr, E., Mourad, J.J., Kahan, T., Persu, A., Chapman, N., Ormezzano, O., Widimsky, J., Papadakis, I., Kantola, I., Deinum, J., Guerrot, D., Gordin, D., MacIntyre, I.M., Silhol, F., Rubin, S., Camafort, M., Lopez-Sublet, M., Sokolovic, S., Papadopoulos, D., Tsioufis, K., Bursztyn, M., Lueders, S., Tengiz, I., Weber, T., Mallamaci, F., Huart, J., Marketou, M., Muiesan, M.L., Gaciong, Z., Burkard, T., Oliveras, A., Grassos, C., Nilsson, P., Fauvel, J.P., Sanidas, E., Stergiou, G., Mazza, A., Václavík, J., Schmieder, R., Sudano, I., Duly-Bouhanick, B., Sarafidis, P., Manolis, A., Delmotte, P., Pucci, G., Grassi, G., Cottone, S., Pontremoli, R., Doumas, M., Soucek, M., Fesler, P., Sarzani, R., Kociánová, E., Zebekakis, P., Vogt, L., Dorobantu, M., Járai, Z., Veglio, F., de Backer, T., Perl, S., Azizi, M., Gkaliagkousi, E., Halimi, J.M.   +84 more
core   +1 more source

Incident Comorbid Diabetes and Outcomes in Multiple Sclerosis: An English Population‐Based Cohort Study

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective To compare the incidence of diabetes mellitus and its associations with hospitalisation and mortality in adults with multiple sclerosis (MS) and matched controls. Methods Using English primary care data from the Clinical Practice Research Datalink, linked to hospital and mortality records, we matched adults with MS with up to 10 ...
Yolanda Lau, Sedigheh Zabihi, Morghan Hartmann, Georgina Mathlin, Sube Banerjee, Ebaa Marouf, Clare Hadley, Claudia Cooper, Ruth Dobson   +8 more
wiley   +1 more source

’Malignant’ hypertension from hyperaldosteronism: a case report

The Pan African Medical Journal, 2018
Adrenocortical carcinomas (ACC) are rare with an incidence of 0.7-2 per million population per year and account for only 0.05%-2% of all malignant tumors. While majority of the functional ACC present as Cushing syndrome, recurrent hyperaldosteronism from
Krishna Mohan Baradhi, Thao Tran, Penchala Swamy Mittadodla   +2 more
doaj   +1 more source

Investigation of Complement Activation and Cytokine Signatures in AQP4+ NMOSD, MOGAD, and MS

Annals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Aquaporin‐4‐IgG seropositive neuromyelitis optica spectrum disorder (AQP4+ NMOSD), myelin oligodendrocyte glycoprotein antibody‐associated disease (MOGAD), and multiple sclerosis (MS) are pathophysiologically distinct neuroinflammatory disorders. Complement activation is a major mechanism of injury in AQP4+ NMOSD, whereas its role in
Angeliki G. Filippatou, Susana Dominguez‐Penuela, David Acero‐Garces, Georgios Gakis, Matthew D. Smith, Yasmin Resto, Maria Reyes‐Mantilla, Haiwen Chen, Isabella Hernandez, Yana Said, Andrea Salazar‐Camelo, Christina Huynh, Alessia Tassoni, Ted Yednock, Rick Artis, Yaisa Andrews‐Zwilling, Scott D. Newsome, Shiv Saidha, Pavan Bhargava, Ellen M. Mowry, Kathryn C. Fitzgerald, Peter A. Calabresi, Carlos A. Pardo, Elias S. Sotirchos   +23 more
wiley   +1 more source

Artificial Intelligence in Systemic Sclerosis: Clinical Applications, Challenges, and Future Directions

Arthritis Care &Research, EarlyView.
Systemic sclerosis (SSc) is a rare autoimmune disease defined by immune dysregulation, vasculopathy, and progressive fibrosis of the skin and internal organs. Despite advances in care, major complications such as interstitial lung disease (ILD) and myocardial involvement remain the leading causes of morbidity and mortality.
Cristiana Sieiro Santos, José Miguel Sequí‐Sabater, Diego Benavent   +2 more
wiley   +1 more source

Normokalemic primary hyperaldosteronism - A common cause of secondary hypertension

, 1999
Recently, some genetic forms of hypertension have been well characterized. These forms can be globally called mineralocorticoid hypertension and are due to different alterations of the renin-angiotensin-aldosterone system (SRAA).
Rojas, P., Mosso, L., Fardella, C., Rojas, A., Montero, J., Soto, J., Foradori, A., Sanchez, O., Huete, A.   +8 more
core  

Hypertension and happiness across nations [PDF]

, 2007
In surveys of well-being, countries such as Denmark and the Netherlands emerge as particularly happy while nations like Germany and Italy report lower levels of happiness. But are these kinds of findings credible?
Blanchflower, David, Oswald, Andrew J, Oswald, Andrew J., Blanchflower, David G.   +3 more
core   +1 more source

Real‐World Safety and Effectiveness of JAK Inhibitors in Systemic Sclerosis: A Propensity‐Matched Study From the EUSTAR Cohort

Arthritis Care &Research, EarlyView.
Objective JAK inhibitors (JAKi) have shown promising effects in early‐phase studies of systemic sclerosis (SSc). We aimed to assess the safety and explore the effectiveness of JAKi compared to conventional immunosuppressants in SSc. Methods A longitudinal retrospective study of the European Scleroderma Trials and Research Group (EUSTAR) cohort was ...
Stefano Di Donato, Marie‐Elise Truchetet, Marco Minerba, Oliver Distler, Juan José Alegre Sancho, Yolanda Braun‐Moscovici, Christina Bergmann, Petros Sfikakis, Jeska K. de Vries‐Bouwstra, Murray Baron, Silvia Bellando‐Randone, Lorenzo Dagna, Christopher P. Denton, Madelon C. Vonk, Vanessa Smith, Ivan Castellvi, Gabriela Riemekasten, Andra Balanescu, Masataka Kuwana, Maria De Santis, Kamal Solanki, Anastas Batalov, Vahan Mukuchyan, Marco Matucci‐Cerinic, Yannick Allanore, Francesco Del Galdo, Michael Hughes, EUSTAR Collaborators   +27 more
wiley   +1 more source

Short‐Term Response to Biologic Therapy in Psoriatic Arthritis Is Not Influenced by Disease Duration at Initiation of Therapy

Arthritis Care &Research, EarlyView.
Objective We aimed to determine whether the short‐term response to biologics in biologic‐naive psoriatic arthritis (PsA) is better in patients initiating biologic treatment early in the disease course. Methods Patients with PsA who started on biologic therapy from the year 2000 to 2025 were included for analysis.
Sung Min Cho, Shangyi Gao, Daniel Pereira, Richard J. Cook, Dafna D. Gladman   +4 more
wiley   +1 more source